Gene expression in tree shrew choroid was examined during the development of
minus-lens induced myopia (LIM, a GO condition), after completion of minus-lens
compensation (a STAY condition), and early in recovery (REC) from induced myopia (a STOP
condition). Five groups of tree shrews (n = 7 per group) were used. Starting 24
days after normal eye-opening (days of visual experience [DVE]), one
minus-lens group wore a monocular −5 D lens for 2 days (LIM-2), another minus-lens
group achieved stable lens compensation while wearing a monocular −5 D lens for 11
days (LIM-11); a recovery group also wore a −5D lens for 11 days and then received
2 days of recovery starting at 35 DVE (REC-2). Two age-matched normal groups were examined
at 26 DVE and 37 DVE. Quantitative PCR was used to measure the relative differences in
mRNA levels in the choroid for 77 candidate genes that were selected based on previous
studies or because a whole-transcriptome analysis suggested their expression would change
during myopia development or recovery. Small myopic changes were observed in the treated
eyes of the LIM-2 group (−1.0 ± 0.2 D; mean ± SEM) indicating eyes
were early in the process of developing LIM. The LIM-11 group exhibited complete
refractive compensation (−5.1 ± 0.2 D) that was stable for five days. The
REC-2 group recovered by 1.3 ± 0.3 D from full refractive compensation. Sixty
genes showed significant mRNA expression differences during normal development, LIM, or
REC conditions. In LIM-2 choroid (GO), 18 genes were significantly down-regulated in the
treated eyes relative to the fellow control eyes and 10 genes were significantly
up-regulated. In LIM-11 choroid (STAY), 10 genes were significantly down-regulated and 12
genes were significantly up-regulated. Expression patterns in GO and STAY were similar,
but not identical. All genes that showed differential expression in GO and STAY were
regulated in the same direction in both conditions. In REC-2 choroid (STOP), 4 genes were
significantly down-regulated and 18 genes were significantly up-regulated. Thirteen genes
showed bi-directional regulation in GO vs. STOP. The pattern of differential gene
expression in STOP was very different from that in GO or in STAY. Significant regulation
was observed in genes involved in signaling as well as extracellular matrix turnover.
These data support an active role for the choroid in the signaling cascade from retina to
sclera. Distinctly different treated eye vs. control eye mRNA signatures are present in
the choroid in the GO, STAY, and STOP conditions. The STAY signature, present after full
compensation has occurred and the GO visual stimulus is no longer present, may participate
in maintaining an elongated globe. The 13 genes with bi-directional expression differences
in GO and STOP responded in a sign of defocus-dependent manner. Taken together, these data
further suggest that a network of choroidal gene expression changes generate the signal
that alters scleral fibroblast gene expression and axial elongation rate.